Stay updated on Cabozantinib Pembrolizumab Combo in Advanced Melanoma Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib Pembrolizumab Combo in Advanced Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib Pembrolizumab Combo in Advanced Melanoma Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The page now shows a glossary, adds a 'Last Update Submitted that Met QC Criteria' field, a 'No FEAR Act Data' indicator, and a 'Revision: v3.4.0' note. The previous 'Last Update Submitted that met QC Criteria' field, FEAR Act wording, and the older 'Revision: v3.3.4' version have been removed.
    Difference
    0.2%
    Check dated 2026-01-29T07:34:09.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The label 'Last Update Posted (Estimated)' was changed to 'Last Update Posted'.
    Difference
    0.1%
    Check dated 2026-01-22T05:16:28.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The page revision label changed from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-15T03:29:04.000Z thumbnail image
  4. Check
    43 days ago
    Change Detected
    Summary
    Added a Locations section with the Iowa site details. Removed the Iowa Locations block and the HHS Vulnerability Disclosure link, and updated the page revision to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T21:43:03.000Z thumbnail image
  5. Check
    72 days ago
    Change Detected
    Summary
    Revision history updated: added Revision: v3.3.2 and removed Revision: v3.2.0.
    Difference
    0.1%
    Check dated 2025-11-25T11:53:16.000Z thumbnail image
  6. Check
    79 days ago
    Change Detected
    Summary
    Removed the government funding lapse notice banner that warned users about possible delays and operating status changes. The banner previously conveyed site-wide operational information.
    Difference
    0.4%
    Check dated 2025-11-18T07:20:31.000Z thumbnail image

Stay in the know with updates to Cabozantinib Pembrolizumab Combo in Advanced Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib Pembrolizumab Combo in Advanced Melanoma Clinical Trial page.